Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of venlafaxine extended-release 150 mg vs Efexor XR 150 mg in healthy Thai volunteers
TCTR20240705003Phase 1Unknown
- Sponsor
- Bio-innova
- Start
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of venlafaxine in major depressive disorder (MDD), generalized anxiety disorder (GAD), Social Anxiety Disorder (SAD) and 1 more (2 arms), sponsored by Bio-innova. Status: unknown.
02
Drugs
venlafaxine
03
Conditions
major depressive disorder (MDD)generalized anxiety disorder (GAD)Social Anxiety Disorder (SAD)panic disorder
Beyond the preview
Go deeper on TCTR20240705003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20240705003.